PK
Therapeutic Areas
Fulgent Genetics Pipeline
| Drug | Indication | Phase |
|---|---|---|
| Nanoencapsulation & Targeted Therapy Platform | Broad range of cancers | Pre-clinical |
Leadership Team at Fulgent Genetics
MH
Ming Hsieh
Founder, Chairman of the Board, and Chief Executive Officer (CEO)
BP
Brandon Perthuis
Chief Commercial Officer (CCO)
DH
Dr. Harry Gao
Chief Scientific Officer (CSO)
KL
Kathy L. Valentine
Chief Legal Officer and Corporate Secretary